25 XP   0   0   10

Biosyent Inc.
Buy, Hold or Sell?

Let's analyse Biosyent together

PenkeI guess you are interested in Biosyent Inc.. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Biosyent Inc.. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Biosyent Inc.

I send you an email if I find something interesting about Biosyent Inc..

Quick analysis of Biosyent (30 sec.)










What can you expect buying and holding a share of Biosyent? (30 sec.)

How much money do you get?

How much money do you get?
C$0.12
When do you have the money?
1 year
How often do you get paid?
20.7%

What is your share worth?

Current worth
C$2.96
Expected worth in 1 year
C$3.16
How sure are you?
89.7%

+ What do you gain per year?

Total Gains per Share
C$0.36
Return On Investment
4.3%

For what price can you sell your share?

Current Price per Share
C$8.55
Expected price per share
C$8.41 - C$8.82
How sure are you?
50%

1. Valuation of Biosyent (5 min.)




Live pricePrice per Share (EOD)

C$8.55

Intrinsic Value Per Share

C$-1.49 - C$-1.96

Total Value Per Share

C$1.47 - C$1.00

2. Growth of Biosyent (5 min.)




Is Biosyent growing?

Current yearPrevious yearGrowGrow %
How rich?$25.1m$23.7m$847k3.4%

How much money is Biosyent making?

Current yearPrevious yearGrowGrow %
Making money$1.1m$987.2k$181.1k15.5%
Net Profit Margin20.2%19.6%--

How much money comes from the company's main activities?

3. Financial Health of Biosyent (5 min.)




What can you expect buying and holding a share of Biosyent? (5 min.)

Welcome investor! Biosyent's management wants to use your money to grow the business. In return you get a share of Biosyent.

What can you expect buying and holding a share of Biosyent?

First you should know what it really means to hold a share of Biosyent. And how you can make/lose money.

Speculation

The Price per Share of Biosyent is C$8.55. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Biosyent.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Biosyent, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is C$2.96. Based on the TTM, the Book Value Change Per Share is C$0.05 per quarter. Based on the YOY, the Book Value Change Per Share is C$0.06 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is C$0.04 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Biosyent.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 C$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per ShareC$% of Price per Share
Usd Eps0.091.0%0.101.2%0.080.9%0.080.9%0.070.9%
Usd Book Value Change Per Share0.030.3%0.040.4%0.040.5%0.040.5%0.070.9%
Usd Dividend Per Share0.030.3%0.030.3%0.010.2%0.010.1%0.010.1%
Usd Total Gains Per Share0.060.7%0.070.8%0.060.7%0.050.6%0.080.9%
Usd Price Per Share6.67-5.79-5.72-5.23-5.59-
Price to Earnings Ratio18.65-15.70-17.84-19.19-20.92-
Price-to-Total Gains Ratio118.17-113.80-100.46-128.84-98.10-
Price to Book Ratio3.11-2.80-2.96-3.10-3.96-
Price-to-Total Gains Ratio118.17-113.80-100.46-128.84-98.10-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share6.185925
Number of shares161
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.030.01
Usd Book Value Change Per Share0.040.04
Usd Total Gains Per Share0.070.05
Gains per Quarter (161 shares)10.598.06
Gains per Year (161 shares)42.3732.25
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
119243262722
2374774115354
35671116178086
4759415822107118
59411820028133150
611214224234160182
713116528439187214
815018932645213246
916921336850240278
1018723641056266310

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share4.00.00.0100.0%12.00.00.0100.0%20.00.00.0100.0%29.00.00.0100.0%29.00.00.0100.0%
Book Value Change Per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%26.03.00.089.7%26.03.00.089.7%
Dividend per Share4.00.00.0100.0%6.00.06.050.0%6.00.014.030.0%6.00.023.020.7%6.00.023.020.7%
Total Gains per Share4.00.00.0100.0%12.00.00.0100.0%19.01.00.095.0%26.03.00.089.7%26.03.00.089.7%

Fundamentals of Biosyent

About Biosyent Inc.

BioSyent Inc., through its subsidiaries, acquires or licenses, develops, and sells pharmaceutical and other healthcare products in Canada and internationally. Its products include FeraMAX Pd Therapeutic 150 for the treatment of iron deficiency anemia; FeraMAX Pd Maintenance 45, a chewable supplement for the prevention of iron deficiency anemia; and FeraMAX Pd Powder 15, a powder form product used for preventing iron deficiency and iron deficiency anemia. It also offers Tibella, a hormone replacement therapy consisting of tibolone; Inofolic, a natural health product to address polycystic ovarian syndrome symptoms; RepaGyn, a vaginal suppository for the healing of the vaginal mucosa, as well as for the treatment of vaginal dryness caused by aging, menopause, stress, and chemotherapy; and Gelclair, a gel formulated to aid the pain or oral mucositis. In addition, the company provides Cathejell, a lubricant with anesthetic with the indication of lubricating and opening the urethra before the insertion of the catheter; Combogesic to manage mild to moderate acute pain and reduction of fever in adults; and Proktis-M, a rectal suppository for the healing of the anus and rectum. The company sells its products through wholesalers and retail pharmacy chains. The company was formerly known as Hedley Technologies Inc. and changed its name to BioSyent Inc. in June 2006. BioSyent Inc. was founded in 2006 and is headquartered in Mississauga, Canada.

Fundamental data was last updated by Penke on 2024-04-09 15:47:03.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge profit.
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating less efficient.
The company is less efficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is underpriced.
Based on the earnings, the company is fair priced.
Based on how much money comes from the company's main activities, the company is cheap.

1.1. Profitability of Biosyent Inc..

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Biosyent earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of 17.5% means that $0.18 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Biosyent Inc.:

  • The MRQ is 17.5%. The company is making a huge profit. +2
  • The TTM is 20.2%. The company is making a huge profit. +2
Trends
Current periodCompared to+/- 
MRQ17.5%TTM20.2%-2.7%
TTM20.2%YOY19.6%+0.6%
TTM20.2%5Y19.8%+0.4%
5Y19.8%10Y21.5%-1.7%
1.1.2. Return on Assets

Shows how efficient Biosyent is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • 3.5% Return on Assets means that Biosyent generated $0.03 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Biosyent Inc.:

  • The MRQ is 3.5%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.0%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ3.5%TTM4.0%-0.5%
TTM4.0%YOY3.5%+0.5%
TTM4.0%5Y3.7%+0.3%
5Y3.7%10Y4.2%-0.5%
1.1.3. Return on Equity

Shows how efficient Biosyent is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • 4.2% Return on Equity means Biosyent generated $0.04 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Biosyent Inc.:

  • The MRQ is 4.2%. Using its investors money, the company is inefficient in making profit. -1
  • The TTM is 4.7%. Using its investors money, the company is inefficient in making profit. -1
Trends
Current periodCompared to+/- 
MRQ4.2%TTM4.7%-0.6%
TTM4.7%YOY4.2%+0.6%
TTM4.7%5Y4.4%+0.3%
5Y4.4%10Y4.9%-0.5%

1.2. Operating Efficiency of Biosyent Inc..

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Biosyent is operating .

  • Measures how much profit Biosyent makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Biosyent Inc.:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM10.9%-10.9%
TTM10.9%YOY25.1%-14.2%
TTM10.9%5Y23.1%-12.2%
5Y23.1%10Y25.6%-2.5%
1.2.2. Operating Ratio

Measures how efficient Biosyent is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 1.01 means that the operating costs are $1.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Biosyent Inc.:

  • The MRQ is 1.007. The company is inefficient in keeping operating costs low. -1
  • The TTM is 0.952. The company is less efficient in keeping operating costs low.
Trends
Current periodCompared to+/- 
MRQ1.007TTM0.952+0.054
TTM0.952YOY0.933+0.019
TTM0.9525Y0.954-0.002
5Y0.95410Y0.943+0.012

1.3. Liquidity of Biosyent Inc..

1.3. Liquidity
1.3.1. Current Ratio

Measures if Biosyent is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 6.48 means the company has $6.48 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Biosyent Inc.:

  • The MRQ is 6.482. The company is very able to pay all its short-term debts. +2
  • The TTM is 7.371. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ6.482TTM7.371-0.889
TTM7.371YOY7.950-0.579
TTM7.3715Y7.738-0.367
5Y7.73810Y8.226-0.488
1.3.2. Quick Ratio

Measures if Biosyent is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 3.79 means the company can pay off $3.79 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Biosyent Inc.:

  • The MRQ is 3.795. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 4.587. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ3.795TTM4.587-0.792
TTM4.587YOY4.792-0.205
TTM4.5875Y3.596+0.991
5Y3.59610Y3.731-0.135

1.4. Solvency of Biosyent Inc..

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Biosyent assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Biosyent to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.16 means that Biosyent assets are financed with 16.3% credit (debt) and the remaining percentage (100% - 16.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Biosyent Inc.:

  • The MRQ is 0.163. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.157. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.163TTM0.157+0.006
TTM0.157YOY0.156+0.002
TTM0.1575Y0.160-0.002
5Y0.16010Y0.144+0.016
1.4.2. Debt to Equity Ratio

Measures if Biosyent is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 19.5% means that company has $0.19 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Biosyent Inc.:

  • The MRQ is 0.195. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.187. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.195TTM0.187+0.008
TTM0.187YOY0.185+0.002
TTM0.1875Y0.191-0.004
5Y0.19110Y0.169+0.021

2. Market Valuation of Biosyent Inc.

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every $1 in earnings Biosyent generates.

  • Above 15 is considered overpriced but always compare Biosyent to the Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of 18.65 means the investor is paying $18.65 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Biosyent Inc.:

  • The EOD is 17.299. Based on the earnings, the company is fair priced.
  • The MRQ is 18.654. Based on the earnings, the company is fair priced.
  • The TTM is 15.699. Based on the earnings, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD17.299MRQ18.654-1.356
MRQ18.654TTM15.699+2.955
TTM15.699YOY17.843-2.144
TTM15.6995Y19.194-3.495
5Y19.19410Y20.916-1.722
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Biosyent Inc.:

  • The EOD is 40.306. Based on how much money comes from the company's main activities, the company is fair priced.
  • The MRQ is 43.465. Based on how much money comes from the company's main activities, the company is fair priced.
  • The TTM is 10.354. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD40.306MRQ43.465-3.158
MRQ43.465TTM10.354+33.111
TTM10.354YOY-37.035+47.389
TTM10.3545Y-3.869+14.223
5Y-3.86910Y7.665-11.534
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Biosyent is to cheap or to expensive compared to its book value.

Let's take a look of the Price to Book Ratio trends of Biosyent Inc.:

  • The EOD is 2.888. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.114. Based on the equity, the company is fair priced.
  • The TTM is 2.800. Based on the equity, the company is underpriced. +1
Trends
Current periodCompared to+/- 
EOD2.888MRQ3.114-0.226
MRQ3.114TTM2.800+0.315
TTM2.800YOY2.964-0.165
TTM2.8005Y3.103-0.304
5Y3.10310Y3.962-0.859
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Biosyent Inc. compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share--0.0380.051-25%0.061-38%0.057-34%0.102-63%
Book Value Per Share--2.9612.857+4%2.676+11%2.348+26%2.095+41%
Current Ratio--6.4827.371-12%7.950-18%7.738-16%8.226-21%
Debt To Asset Ratio--0.1630.157+4%0.156+5%0.160+2%0.144+13%
Debt To Equity Ratio--0.1950.187+4%0.185+5%0.191+2%0.169+15%
Dividend Per Share--0.0400.0400%0.020+102%0.012+234%0.008+385%
Eps--0.1240.136-9%0.111+11%0.105+18%0.101+22%
Free Cash Flow Per Share--0.0530.103-49%0.091-42%0.091-42%0.099-46%
Free Cash Flow To Equity Per Share---0.057-0.018-68%0.002-3558%0.005-1292%0.037-252%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---1.963--------
Intrinsic Value_10Y_min---1.490--------
Intrinsic Value_1Y_max--0.297--------
Intrinsic Value_1Y_min--0.292--------
Intrinsic Value_3Y_max--0.516--------
Intrinsic Value_3Y_min--0.500--------
Intrinsic Value_5Y_max--0.282--------
Intrinsic Value_5Y_min--0.294--------
Market Cap99284310.000-9%108252628.52095123728.983+14%96987815.760+12%91379805.691+18%102727352.959+5%
Net Profit Margin--0.1750.202-13%0.196-11%0.198-11%0.215-18%
Operating Margin---0.109-100%0.251-100%0.231-100%0.256-100%
Operating Ratio--1.0070.952+6%0.933+8%0.954+5%0.943+7%
Pb Ratio2.888-8%3.1142.800+11%2.964+5%3.103+0%3.962-21%
Pe Ratio17.299-8%18.65415.699+19%17.843+5%19.194-3%20.916-11%
Price Per Share8.550-8%9.2208.008+15%7.910+17%7.225+28%7.731+19%
Price To Free Cash Flow Ratio40.306-8%43.46510.354+320%-37.035+185%-3.869+109%7.665+467%
Price To Total Gains Ratio109.580-8%118.167113.803+4%100.456+18%128.844-8%98.101+20%
Quick Ratio--3.7954.587-17%4.792-21%3.596+6%3.731+2%
Return On Assets--0.0350.040-12%0.035-1%0.037-6%0.042-18%
Return On Equity--0.0420.047-12%0.042+0%0.044-6%0.049-15%
Total Gains Per Share--0.0780.091-14%0.081-4%0.069+13%0.110-29%
Usd Book Value--25148683.46624562971.147+2%23715942.928+6%21414167.470+17%19746475.047+27%
Usd Book Value Change Per Share--0.0270.037-25%0.044-38%0.041-34%0.074-63%
Usd Book Value Per Share--2.1422.067+4%1.936+11%1.699+26%1.516+41%
Usd Dividend Per Share--0.0290.0290%0.014+102%0.009+234%0.006+385%
Usd Eps--0.0890.098-9%0.081+11%0.076+18%0.073+22%
Usd Free Cash Flow--450485.105882804.571-49%801174.779-44%825174.504-45%944703.813-52%
Usd Free Cash Flow Per Share--0.0380.075-49%0.066-42%0.066-42%0.072-46%
Usd Free Cash Flow To Equity Per Share---0.041-0.013-68%0.001-3558%0.003-1292%0.027-252%
Usd Market Cap71832198.285-9%78320776.73468822017.919+14%70170684.702+12%66113289.417+18%74323239.866+5%
Usd Price Per Share6.186-8%6.6715.793+15%5.723+17%5.227+28%5.593+19%
Usd Profit--1049647.2891168475.471-10%987278.152+6%953741.865+10%957294.110+10%
Usd Revenue--5986011.8215713895.874+5%5050968.199+19%4771127.949+25%4470472.820+34%
Usd Total Gains Per Share--0.0560.066-14%0.059-4%0.050+13%0.080-29%
 EOD+4 -4MRQTTM+8 -27YOY+14 -215Y+16 -1910Y+16 -19

3.2. Fundamental Score

Let's check the fundamental score of Biosyent Inc. based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1517.299
Price to Book Ratio (EOD)Between0-12.888
Net Profit Margin (MRQ)Greater than00.175
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than13.795
Current Ratio (MRQ)Greater than16.482
Debt to Asset Ratio (MRQ)Less than10.163
Debt to Equity Ratio (MRQ)Less than10.195
Return on Equity (MRQ)Greater than0.150.042
Return on Assets (MRQ)Greater than0.050.035
Total5/10 (50.0%)

3.3. Technical Score

Let's check the technical score of Biosyent Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.208
Ma 20Greater thanMa 508.637
Ma 50Greater thanMa 1008.629
Ma 100Greater thanMa 2008.642
OpenGreater thanClose8.530
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in CAD. All numbers in thousands.

Summary
Total Assets41,529
Total Liabilities6,769
Total Stockholder Equity34,760
 As reported
Total Liabilities 6,769
Total Stockholder Equity+ 34,760
Total Assets = 41,529

Assets

Total Assets41,529
Total Current Assets35,871
Long-term Assets5,657
Total Current Assets
Cash And Cash Equivalents 7,985
Short-term Investments 18,202
Net Receivables 2,798
Inventory 5,894
Total Current Assets  (as reported)35,871
Total Current Assets  (calculated)34,879
+/- 992
Long-term Assets
Property Plant Equipment 1,440
Long Term Investments 2,500
Intangible Assets 1,153
Long-term Assets  (as reported)5,657
Long-term Assets  (calculated)5,093
+/- 565

Liabilities & Shareholders' Equity

Total Current Liabilities5,534
Long-term Liabilities1,235
Total Stockholder Equity34,760
Total Current Liabilities
Accounts payable 5,078
Other Current Liabilities 27
Total Current Liabilities  (as reported)5,534
Total Current Liabilities  (calculated)5,105
+/- 429
Long-term Liabilities
Capital Lease Obligations Min Short Term Debt1,221
Long-term Liabilities  (as reported)1,235
Long-term Liabilities  (calculated)1,221
+/- 14
Total Stockholder Equity
Retained Earnings 27,528
Total Stockholder Equity (as reported)34,760
Total Stockholder Equity (calculated)27,528
+/- 7,232
Other
Capital Stock5,122
Common Stock Shares Outstanding 11,741
Net Invested Capital 34,760
Net Working Capital 30,338
Property Plant and Equipment Gross 3,324



Balance Sheet

Currency in CAD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-31
> Total Assets 
19,248
19,807
21,722
23,026
25,105
25,927
28,314
29,373
31,188
30,017
28,043
30,018
30,965
31,141
30,551
31,879
33,571
33,250
34,339
37,325
37,167
37,874
37,980
39,015
40,485
38,749
39,513
41,397
41,529
41,52941,39739,51338,74940,48539,01537,98037,87437,16737,32534,33933,25033,57131,87930,55131,14130,96530,01828,04330,01731,18829,37328,31425,92725,10523,02621,72219,80719,248
   > Total Current Assets 
17,542
18,049
19,398
20,653
22,703
23,504
25,672
26,751
28,352
27,131
25,562
25,303
26,845
27,133
26,637
28,116
29,774
29,550
31,130
34,213
34,079
34,829
34,728
35,774
37,143
35,593
36,518
38,497
35,871
35,87138,49736,51835,59337,14335,77434,72834,82934,07934,21331,13029,55029,77428,11626,63727,13326,84525,30325,56227,13128,35226,75125,67223,50422,70320,65319,39818,04917,542
       Cash And Cash Equivalents 
13,056
13,353
10,511
12,323
12,652
2,554
4,932
11,415
16,833
13,374
10,801
10,714
13,442
17,648
14,429
18,158
20,291
18,978
15,649
18,791
18,035
18,300
6,309
8,204
7,865
6,418
9,298
9,666
7,985
7,9859,6669,2986,4187,8658,2046,30918,30018,03518,79115,64918,97820,29118,15814,42917,64813,44210,71410,80113,37416,83311,4154,9322,55412,65212,32310,51113,35313,056
       Short-term Investments 
683
691
4,191
4,186
6,686
17,085
16,082
11,190
7,592
9,085
9,099
9,098
8,532
3,544
7,039
5,544
5,286
5,046
9,164
8,311
10,176
8,544
21,589
19,581
20,831
19,831
18,624
19,624
18,202
18,20219,62418,62419,83120,83119,58121,5898,54410,1768,3119,1645,0465,2865,5447,0393,5448,5329,0989,0999,0857,59211,19016,08217,0856,6864,1864,191691683
       Net Receivables 
1,941
1,878
2,781
2,561
2,309
2,201
2,562
2,297
2,115
1,969
2,808
2,588
2,084
3,681
2,790
2,618
1,815
2,393
3,728
4,162
3,207
4,689
3,491
3,458
3,657
4,222
3,739
3,370
2,798
2,7983,3703,7394,2223,6573,4583,4914,6893,2074,1623,7282,3931,8152,6182,7903,6812,0842,5882,8081,9692,1152,2972,5622,2012,3092,5612,7811,8781,941
       Inventory 
1,560
1,737
1,482
1,275
909
1,194
1,734
1,340
1,483
1,992
2,068
2,105
2,139
1,523
1,827
1,247
2,074
2,706
2,258
2,470
2,204
2,657
2,775
4,170
4,535
4,708
4,220
4,564
5,894
5,8944,5644,2204,7084,5354,1702,7752,6572,2042,4702,2582,7062,0741,2471,8271,5232,1392,1052,0681,9921,4831,3401,7341,1949091,2751,4821,7371,560
       Other Current Assets 
32
50
108
0
0
0
146
38
27
73
50
33
0
0
0
20
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000002000033507327381460001085032
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
2,886
2,481
4,715
4,120
4,009
3,914
3,762
3,797
3,700
3,209
3,112
3,088
3,045
3,251
3,241
3,342
3,156
2,995
2,900
5,657
5,6572,9002,9953,1563,3423,2413,2513,0453,0883,1123,2093,7003,7973,7623,9144,0094,1204,7152,4812,886000000000
       Property Plant Equipment 
189
187
213
214
198
195
194
184
178
182
193
2,433
2,358
2,289
2,217
2,145
2,075
2,010
1,940
1,876
1,847
1,799
1,733
1,801
1,673
1,602
1,534
1,474
1,440
1,4401,4741,5341,6021,6731,8011,7331,7991,8471,8761,9402,0102,0752,1452,2172,2892,3582,433193182178184194195198214213187189
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2,500
2,5000000000000000000000000000000
       Intangible Assets 
1,324
1,386
1,540
1,619
1,703
1,719
1,938
1,929
1,967
1,935
1,506
1,525
1,023
982
966
911
1,008
965
921
895
874
864
951
943
1,201
1,258
1,222
1,188
1,153
1,1531,1881,2221,2581,2019439518648748959219651,0089119669821,0231,5251,5061,9351,9671,9291,9381,7191,7031,6191,5401,3861,324
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
2,886
2,481
4,715
4,120
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000004,1204,7152,4812,886000000000
> Total Liabilities 
2,521
2,088
2,363
2,287
2,892
2,491
3,130
2,818
3,583
3,057
3,238
4,633
5,171
5,490
5,461
5,759
6,775
5,502
5,534
6,993
5,613
5,841
5,253
6,020
7,123
5,329
6,443
6,845
6,769
6,7696,8456,4435,3297,1236,0205,2535,8415,6136,9935,5345,5026,7755,7595,4615,4905,1714,6333,2383,0573,5832,8183,1302,4912,8922,2872,3632,0882,521
   > Total Current Liabilities 
2,358
1,952
2,163
2,094
2,616
2,206
2,771
2,462
3,214
2,685
2,969
2,630
3,359
3,743
3,736
4,022
5,139
3,892
3,964
5,431
4,137
4,306
3,737
4,514
5,719
3,947
5,136
5,600
5,534
5,5345,6005,1363,9475,7194,5143,7374,3064,1375,4313,9643,8925,1394,0223,7363,7433,3592,6302,9692,6853,2142,4622,7712,2062,6162,0942,1631,9522,358
       Accounts payable 
2,129
1,648
2,163
1,947
2,539
1,841
2,661
2,174
2,780
2,315
2,295
2,426
2,917
2,794
2,558
2,661
3,723
3,196
3,301
4,727
3,563
3,351
3,332
4,039
5,063
3,569
3,832
5,158
5,078
5,0785,1583,8323,5695,0634,0393,3323,3513,5634,7273,3013,1963,7232,6612,5582,7942,9172,4262,2952,3152,7802,1742,6611,8412,5391,9472,1631,6482,129
       Other Current Liabilities 
229
304
0
147
76
366
110
287
434
370
673
61
298
803
1,030
1,211
1,263
542
506
546
412
790
236
304
482
202
1,125
0
27
2701,1252024823042367904125465065421,2631,2111,03080329861673370434287110366761470304229
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
372
270
2,003
1,812
1,747
1,726
1,737
1,637
1,610
1,570
1,562
1,475
1,536
1,515
1,506
1,403
1,382
1,307
1,246
1,235
1,2351,2461,3071,3821,4031,5061,5151,5361,4751,5621,5701,6101,6371,7371,7261,7471,8122,003270372000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
0
0
0
0
0
0
0
1,876
1,853
1,817
1,782
1,746
1,709
1,671
1,634
1,595
1,557
1,517
1,478
1,437
1,395
1,352
1,309
1,265
1,221
1,2211,2651,3091,3521,3951,4371,4781,5171,5571,5951,6341,6711,7091,7461,7821,8171,8531,87600000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1,403
0
1,307
0
0
001,30701,403000000000000000000000000
       Deferred Long Term Liability 
56
60
60
60
60
60
69
69
69
69
69
110
72
65
57
47
132
129
128
0
124
125
121
139
171
168
166
0
0
001661681711391211251240128129132475765721106969696969606060606056
> Total Stockholder Equity
16,727
17,719
19,359
20,739
22,213
23,436
25,183
26,554
27,606
26,960
24,805
25,384
25,795
25,651
25,089
26,120
26,796
27,749
28,805
30,332
31,555
32,033
32,727
32,995
33,363
33,419
33,070
34,551
34,760
34,76034,55133,07033,41933,36332,99532,72732,03331,55530,33228,80527,74926,79626,12025,08925,65125,79525,38424,80526,96027,60626,55425,18323,43622,21320,73919,35917,71916,727
   Common Stock
7,300
7,414
7,421
7,486
7,518
7,518
7,618
7,618
7,655
7,538
7,336
7,245
7,180
6,577
6,410
6,416
6,392
6,177
6,152
5,842
5,797
5,620
5,581
5,395
5,367
5,330
5,069
0
0
005,0695,3305,3675,3955,5815,6205,7975,8426,1526,1776,3926,4166,4106,5777,1807,2457,3367,5387,6557,6187,6187,5187,5187,4867,4217,4147,300
   Retained Earnings 
8,808
9,710
11,263
12,557
14,014
15,115
16,735
18,006
18,988
18,379
16,392
16,974
17,485
17,872
17,454
18,410
19,076
20,251
21,269
22,957
24,125
24,760
25,352
25,644
25,910
26,221
26,012
27,312
27,528
27,52827,31226,01226,22125,91025,64425,35224,76024,12522,95721,26920,25119,07618,41017,45417,87217,48516,97416,39218,37918,98818,00616,73515,11514,01412,55711,2639,7108,808
   Capital Surplus 00000000000000000000000000000
   Treasury Stock00000000000000000000000000000
   Other Stockholders Equity 
24
1
16
0
1
-4
-25
9
-15
9
-27
-8
-105
-86
-137
-135
-167
-237
-260
-199
-185
-212
-182
-140
-143
-113
-98
0
0
00-98-113-143-140-182-212-185-199-260-237-167-135-137-86-105-8-279-159-25-41016124



Balance Sheet

Currency in CAD. All numbers in thousands.




Cash Flow

Currency in CAD. All numbers in thousands.




Income Statement

Currency in CAD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue31,590
Cost of Revenue-5,992
Gross Profit25,59825,598
 
Operating Income (+$)
Gross Profit25,598
Operating Expense-24,056
Operating Income7,5341,542
 
Operating Expense (+$)
Research Development83
Selling General Administrative17,267
Selling And Marketing Expenses0
Operating Expense24,05617,350
 
Net Interest Income (+$)
Interest Income1,131
Interest Expense-68
Other Finance Cost-0
Net Interest Income1,063
 
Pretax Income (+$)
Operating Income7,534
Net Interest Income1,063
Other Non-Operating Income Expenses0
Income Before Tax (EBT)8,5347,597
EBIT - interestExpense = -68
6,460
6,529
Interest Expense68
Earnings Before Interest and Taxes (EBIT)08,602
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax8,534
Tax Provision-2,074
Net Income From Continuing Ops6,4606,460
Net Income6,460
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net-63-1,063
 

Technical Analysis of Biosyent
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Biosyent. The general trend of Biosyent is BULLISH with 14.3% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Biosyent's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (14.3%) Bearish trend (-14.3%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Biosyent Inc..

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 8.56 < 8.75 < 8.82.

The bearish price targets are: 8.43 > 8.4255 > 8.41.

Tweet this
Biosyent Inc. Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Biosyent Inc.. The current mas is .

The long score for the Moving Averages is 8/14.
The longshort score for the Moving Averages is 2/(-14 +14).

  • MA 20 trending up: The MA 20 is trending up. +1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 > MA 50: The MA 20 is higher than the MA 50. +1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 > MA 200: The MA 20 is higher than the MA 200. +1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 > MA 200: The MA 50 is higher than the MA 200. +1
  • MA 100 trending up: The MA 100 is trending up. +1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 > MA 200: The MA 100 is higher than the MA 200. +1
  • MA 200 trending up: The MA 200 is trending up. +1
  • Close > MA 200: The price is above the MA 200. +1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Biosyent Inc. Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Biosyent Inc.. The current macd is -0.01248854.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biosyent price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Biosyent. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Biosyent price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Biosyent Inc. Daily Moving Average Convergence/Divergence (MACD) ChartBiosyent Inc. Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Biosyent Inc.. The current adx is 12.07.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -2/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Biosyent shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX < 25 && ADX trending up: The ADX is below 25 and indicates a weak or no trend. However, the ADX is rising and a new bearish trend could be forming. -1
Biosyent Inc. Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Biosyent Inc.. The current sar is 8.75.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
Biosyent Inc. Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Biosyent Inc.. The current rsi is 44.21. The current phase is Correction in bull market.

The long score for the Relative Strength Index (RSI) is 0/13.
The longshort score for the Relative Strength Index (RSI) is -3/(-13 +13).

  • Correction in bull market: Moderate price decline, potential pause in the uptrend. Reassess the market, wait for signs of stabilization.
Biosyent Inc. Daily Relative Strength Index (RSI) ChartBiosyent Inc. Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Biosyent Inc.. The current phase is Oversold in bull market.

The long score for the Stochastic Oscillator is 1/6.
The longshort score for the Stochastic Oscillator is -2/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Biosyent price going down in the near term. -2
  • Trending up: The STOCH %K is trending up. +1
Biosyent Inc. Daily Stochastic Oscillator ChartBiosyent Inc. Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Biosyent Inc.. The current cci is -165.10449212.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
Biosyent Inc. Daily Commodity Channel Index (CCI) ChartBiosyent Inc. Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Biosyent Inc.. The current cmo is -20.43365127.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
Biosyent Inc. Daily Chande Momentum Oscillator (CMO) ChartBiosyent Inc. Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Biosyent Inc.. The current willr is -80.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is 0/(-1 +1).

  • WILLR between -80 and -20: The Williams %R is between -80 and -20. This indicates that Biosyent is trading in a neutral price range, neither oversold nor overbought, suggesting a balanced market condition without any extreme price signals.
Biosyent Inc. Daily Williams %R ChartBiosyent Inc. Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Biosyent Inc..

Biosyent Inc. Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Biosyent Inc.. The current atr is 0.08459155.

Biosyent Inc. Daily Average True Range (ATR) ChartBiosyent Inc. Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Biosyent Inc.. The current obv is -113,665.

Biosyent Inc. Daily On-Balance Volume (OBV) ChartBiosyent Inc. Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Biosyent Inc.. The current mfi is 19.20.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Biosyent Inc. Daily Money Flow Index (MFI) ChartBiosyent Inc. Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Biosyent Inc..

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-24STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-11-29STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-04SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-06STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2023-12-13BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-14STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-15RSI SHORT ENTRY LONG CLOSE70 crossover to downside
2023-12-19STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2023-12-20STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-22BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-02RSI SHORT ENTRY LONG CLOSE70 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-03MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-05DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-09STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-11STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-12CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-22STOCH SHORT EXITThe %K line crosses above the %D line.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
2024-01-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-01-26DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-30CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-31STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-02STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-02-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-06CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-07MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-12SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2024-02-15STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-21DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-22MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-26STOCH SHORT EXITThe %K line crosses above the %D line.
2024-02-28STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-02-29DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-01DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-04DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-03-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-06STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-11CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2024-03-18DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-19STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-20STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-03-22STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-25STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-26DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-04-01SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-02CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-04MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2024-04-05CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-08STOCH LONG EXITThe %K line crosses below the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-04-09CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-04-10WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-12CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-04-15MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-04-16STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside

6.3. Candlestick Patterns

Biosyent Inc. Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Biosyent Inc. based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5044.208
Ma 20Greater thanMa 508.637
Ma 50Greater thanMa 1008.629
Ma 100Greater thanMa 2008.642
OpenGreater thanClose8.530
Total2/5 (40.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Biosyent with someone you think should read this too:
  • Are you bullish or bearish on Biosyent? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Biosyent? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Biosyent Inc.

I send you an email if I find something interesting about Biosyent Inc..


Comments

How you think about this?

Leave a comment

Stay informed about Biosyent Inc..

Receive notifications about Biosyent Inc. in your mailbox!